THE PROPORTION OF IVF cycles funded by the NHS has dropped significantly from 40% in 2012 to 27% in 2022, according to the UK fertility regulator, the Human Fertilisation and Embryology Authority (HFEA). This decline is attributed to a variety of factors, including disparities in funding across different regions and the increasing age at which people start IVF treatment.
Regional Disparities in Funding
The HFEA reports that funding for in-vitro fertilisation (IVF) treatment varies “considerably” across the UK, leading to what is often referred to as a “postcode lottery.” In 2022, approximately 52,500 patients received IVF treatment across the UK, compared to 50,000 in 2019. However, in England, NHS funding depends on criteria set by integrated care boards, while in Scotland, Wales, and Northern Ireland, national criteria are applied. Clare Ettinghausen from the HFEA highlighted the inequality in funding on BBC Radio 4’s Today programme, stating, “It is a so-called postcode lottery and we have seen wide-ranging inequalities. So [it can depend on not only] where you live, but your relationship status, whether you have a child from a previous relationship.”
Inequities Based on Demographics
Ettinghausen also pointed out that black patients receive far less funding than white patients, and those in heterosexual couples are most likely to have funding. This disparity is evident in individual stories such as that of David and his partner Ashley. David, who is paralyzed from the chest down, shared on the Today programme that they were declined IVF funding because he has a daughter from a previous relationship. “So apparently that is the rule in the Newcastle areas – but obviously, if I lived in a different part of the UK… we would be allowed it, which, obviously, I think is quite unfair,” he said.
Age and Success Rates
Another significant factor contributing to the decline in NHS-funded IVF cycles is the increasing age of first-time IVF patients. The HFEA’s latest data indicates that the average age for first-time treatment is now over 35. Julia Chain, chair of the HFEA, emphasized the importance of early access to fertility treatment, stating, “IVF success rates continue to improve – but as the chance of a birth rapidly decreases with age, early access to fertility treatment is crucial for those who need it.” The HFEA’s report also notes that the average age of patients starting treatment for the first time is now nearly six years older than the average age at which women in England and Wales gave birth to their first child.
Factors Affecting IVF Access
Several factors have contributed to the reduction in the proportion of IVF cycles funded by the NHS:
- COVID-19 Pandemic: Delays to many NHS services, particularly gynaecology appointments, have been exacerbated by the COVID-19 pandemic. This has resulted in increased waiting times for tests before being offered NHS-funded treatment.
- Cost-of-Living Crisis: The current economic situation has made it difficult for many to fund private treatment. David and Ashley, for example, are now considering private options, which would cost them about £10,000. David mentioned that this would be unaffordable without his father’s help, for which he is “totally thankful.”
- Criteria for Funding: The criteria set by different regions and boards can vary widely, leading to inequalities in access to funded treatment. This regional disparity means that while some patients might receive funding in one area, they might be denied in another.
Success Rates
Despite these challenges, the average IVF pregnancy rates in the UK have risen to 31% per fresh embryo transferred in 2022, up from 21% in 2012. This improvement in success rates highlights the advancements in IVF technology and techniques over the past decade. However, the success rate declines with age, underscoring the need for timely access to treatment.
Conclusion
The fall in the proportion of NHS-funded IVF cycles reflects broader issues within the healthcare system, including regional disparities, demographic inequalities, and the impact of external factors like the pandemic and economic conditions. Addressing these challenges requires a concerted effort to ensure equitable access to fertility treatment for all who need it, regardless of their location, relationship status, or previous parental status. As Julia Chain aptly stated, “Our data shows the average age of patients starting treatment for the first time is now nearly six years older than the average age at which women in England and Wales gave birth to their first child,” highlighting the urgency of providing early and equitable access to IVF treatment.
